News | July 03, 2012

New Echocardiographic Methods Find Cardiac Dysfunction in One of Four Morbidly Obese Patients

July 3, 2012 — Researchers have announced the results of a study that highlights new echocardiographic methods that can detect latent systolic function in obese patients.

“Obesity is a major public health problem in the United States, and increases the risk of various cardiovascular diseases. Our study evaluated both the relaxation and contraction phase of the heart’s function in morbidly obese patients referred for preoperative evaluation prior to bariatric surgery. We found that two out of five morbidly obese patients have abnormalities in the relaxation phase of the heart (stiff hearts). Furthermore, one in five of those with relaxation abnormalities also have early evidence of contraction abnormalities,” explained Farooq A. Chaudhry, MD, Associate Chief of Cardiology, Director of Echocardiography and Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and St. Luke's Roosevelt Hospital Center, New York, NY, senior author of the study.

The study, led by primary investigator Harikrishna Makani, also from Columbia University College of Physicians and Surgeons and St. Luke's Roosevelt Hospital Center, included 340 patients who were referred for stress echocardiography for pre-operative evaluation prior to bariatric surgery. The authors utilized echocardiographic blood and tissue Doppler imaging parameters specifically assessing the relaxation and contraction phase of the heart. They found that abnormalities in the relaxation phase in this patient population are frequently accompanied by early contraction abnormalities as well.

A poster based on the results will be displayed on Monday, July 2, in the poster and exhibit hall at the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions at the Gaylord National, National Harbor, Md. Researchers will be available in the Hall from 12:15 p.m. to 1:45 p.m.

For more information: www.asecho.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now